The purpose of this study was to develop and pilot test a comprehensive measurement tool to quantify all aspects of complementary and alternative medicine (CAM) use among cancer survivors. Data are from 81 cancer patients and survivors with a mean age of 62 years and 77.2% women. CAM was used by 63% of the sample. The most common CAM was regular exercise (50%), meditation (48.5%), and fresh fruit and vegetable juices (38.8%). The main motivations for using CAM were to boost the immune system and enhance quality of life. More than 65% had told a doctor they were using CAM. Reported benefits included feeling better, having more energy, and providing a distraction. The main sources of information were support groups (61.5%), books (50%), and friends (45.3%). Few participants used CAM to cure the cancer, and they had realistic expectations about benefits they may receive from using CAM. Further studies are needed with larger sample sizes to confirm whether findings can be generalized to the broader population of cancer patients and survivors.
A review of 26 surveys conducted in 13 countries concluded that on average 31.4% of adult cancer patients use CAM (Ernst & Cassileth, 1998) . Other studies have found greater proportions of patients use CAM, including rates of 83.3% (Richardson, Sanders, Palmer, Greisinger, & Singletary, 2000) and 49% (Chrystal, Allan, Forgeson, & Isaacs, 2003) . In one study of women with advanced-stage breast cancer, 73% used at least one CAM (Shen et al., 2002) , and in a study of men with prostate cancer, 67% used CAM (Diefenbach et al., 2003) .
Two Australian studies focused on prevalence of CAM use, with 22% of cancer patients found to use CAM (Begbie et al., 1996) and 14.5% of women with cancer found to consult an alternative practitioner (Sibbritt et al., 2003) . A third study additionally examined motivational factors for CAM use by cancer patients (Miller et al., 1998) . The latter study found most patients expected that CAM would aid conventional treatment and make them feel more in control of the situation.
An area in need of examination in greater detail is cancer patients' communication of CAM use with doctors (Adler & Fosket, 1999) . Disclosure of the use of CAM therapies to the person's doctor is important because there is a need to consider possible counterproductive effects of CAM, especially in the context of cancer drugs/treatment received through traditional medicine (McCune et al., 2004) .
The increasing use of CAM by cancer patients and survivors suggests a need for a broader understanding of the whole CAM process in addition to just measuring use of CAM, including reasons for CAM use, the anticipated benefits and actual outcomes, where cancer patients try to find information on CAM, and their communication with doctors regarding CAM use. The purpose of this study was to develop and pilot test a comprehensive measurement tool to quantify all aspects of CAM use among cancer survivors.
METHOD Stage 1: Development of the Questionnaire
To develop a questionnaire that comprehensively covered all aspects of CAM use by cancer survivors, it was imperative to initially conduct in-depth interviews with cancer patients and survivors to generate a range of questions and response options that covered the main domains of interest.
Participants and Procedure
Participants with a range of cancer types, treatments, and different ages were recruited through posters and study flyers placed in the waiting rooms of local doctors' surgeries, a cancer center, and cancer support groups. Inclusion criteria included being 18 years of age or older. Both newly diagnosed patients and survivors who had completed treatment were included.
The interviews were semistructured to ensure the major research questions were systematically covered. Nineteen patients and survivors (5 men and 14 women) aged 43 to 77 completed the in-depth interviews. Ten patients were still undergoing treatment, and 9 had completed treatment at the time of interview.
The information gathered from the interviews was used to form the development of the questionnaire. Data were analyzed for information that addressed key content areas to be included in the questionnaire. The resulting draft questionnaire included demographics and the following sections.
Prevalence, types, and timing of CAM. A detailed list of CAM products/therapies was supplied, and participants were asked to answer the following questions about CAM: whether they tried to find out about the specific CAM, whether they bought it and used it, and whether they received any benefits from that CAM. The CAMs included in the questionnaire were derived from NCCAM, previous literature, and also included medicines and therapies considered by participants in the interviews as being CAM.
Participants were asked when they commenced use of CAM, and whether they were still using CAM. For those reporting not using CAM, the questionnaire contained a component with a list of eight options for reasons.
Motivations for use, and unexpected negative effects.
A question with 23 preset options asked about reasons for commencing, and any expectations of benefits they had prior to using CAM. One question with seven preset options asked about any unexpected negative effects from CAM use. Participants could provide multiple responses to both questions.
Communication with doctor.
Participants were asked if any CAM therapy was recommended by their doctor. If the response was no, they were asked whether they told their doctor they were using CAM. If the response was yes, they were given a list of six doctors they may have disclosed this information too. They were then asked whether the doctor was in favor of, opposed to, or did not offer an opinion about CAM use.
Sources of information on CAM.
The information source section was composed of three items. The first question asked about the source of CAM information and had 12 preset response options. The second asked about confidence in the accuracy of that source of information using a 4-point scale. The third asked whether the use of CAM was supervised by a professional. Additionally, a question asked how well informed the patient felt about CAM compared to others.
Importance of CAM.
The final section included three items that asked about how important CAM was to them for determining whether they remained free/beat the cancer, quality of life, and relieving symptoms. These three items used a 5-point response option from extremely important to not at all important.
The pilot questionnaire was then tested on a separate group of 5 cancer patients, using the "talk aloud" method. Participants were required to read each question and explain what the question was asking of them. This method was used to check respondent understanding of all facets of the questions and response options. Results from this stage were used to refine the wording of any unclear items and to add any additional items or response options.
Stage 2: Pilot Testing the Questionnaire
Participants were recruited through the same posters in medical waiting rooms, the cancer center, and support groups. Interested persons telephoned the researchers, and the questionnaire was sent to them by mail with a return reply, paid envelope. Additionally, an e-mail invitation to participate in the study was sent to all staff (academic and general) at a regional university. Potential participants, who had ever been diagnosed with cancer, could download the questionnaire and return it to the research staff anonymously through the internal mail system.
Interviews and pilot data were collected from July 2004 to February 2005. The study was approved by the University Human Research Ethics Committee.
RESULTS

Participants
A total of 81 participants returned a completed questionnaire; 70 from the posters and 11 from the e-mail invitation. Characteristics of the sample are reported in Tables 1 and 2. The mean age of participants was 62 years (with a range of 34-81 years), and 77.2% of the sample was female. There were no significant differences in the proportion of CAM users by gender or age. There were, however, significant differences in the proportion of participants using CAM by educational achievement, χ 2 = 7.44, p < .02. The proportion of participants with a tertiary qualification using CAM was almost twice that of those with 10 years or less of education.
Prevalence, Types, and Timing of CAM
Fifty-one (63%) of the total sample reported having used at least one CAM since diagnosis. Of those reporting use of CAM, 6% reported using one CAM, 24% reported using two CAMs, and 70% of participants reported using three or more CAMs at some time since diagnosis.
The list of CAM products and therapies in the questionnaire was divided into five sections: diet and nutrition, herbal medicines, mind-body, physical body/relaxation, alternative systems. The five most used CAM products/therapies from each category are reported in Table 3 . The most common CAM was regular exercise, reported by 50% of those using CAM. The next most common CAM was meditation with 48.5%, followed by fresh fruit and Of the 51 participants who reported using CAM at some time since diagnosis, 44% commenced using CAM immediately following diagnosis with cancer, 56.4% reported initiating or continuing to use CAM during treatment, and 67.6% commenced or continued using CAM after treatment was completed. The majority of participants (87%) were currently using at least one CAM.
Reasons for Not Using CAM
Participants who reported not using any CAM (n = 30) in relation to their cancer were asked why they do not do so. The three main reasons reported for not using CAM were not knowing what to use (36.4%), finding conventional medicine worked well enough (32.4%), and deciding there was not enough scientific evidence (30.3%). Other reasons were doctor advised against it (18.2%), not being interested (15.2%), and it might cancel out the doctor's treatment (12%).
Motivation for Use, Actual Benefits Realized, and Negative Effects
Participants reported many reasons for commencing to use CAM, with multiple reasons indicated by most participants. The top 10 reasons are reported in Table 4 . The most frequent motivation for using CAM was to provide a boost to the immune system, followed by enhancing their overall quality of life, doing as much as they could for themselves, and to reduce stress. Only 2 participants chose "cure the cancer" as the reason for using CAM. For the top CAM in each category, the number reporting receiving a benefit was high; for those who reported using fresh juices, 53% felt they received a benefit; 50% felt they received a benefit for herbal medicine use, 51% for regular exercise, 66% for use of a naturopath, and 65% reported a benefit from meditation. Received benefits reported by participants included feel better/healthier (from use of fresh juices, herbal medicine, naturopathy, multi/individual vitamins, vegetarian diet), more energy/fitness (from regular exercise), relaxing/relieves stress (from meditation, massage, yoga or tai chi, prayer or mental healing, acupuncture, reiki, dance or art therapy), and friendship/provides a distraction (from art or dance therapy, yoga or tai chi). Participants were asked to rank the three main reasons for using a particular CAM, but few completed this question. Few negative effects from CAM were reported. The cost of CAM was the most frequent negative finding, although this was only reported by 31% of participants (Table 4) .
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Communication With Doctor
Sixty-five percent of participants had told one of their doctors that they were using CAM, including 18.8% who had CAM recommended by a doctor (Table 5 ). Participants' general practitioner (72.7%) and oncologist (51.2%) were the doctors with whom they most frequently discussed CAM use. Participants were asked about the doctor's response to disclosing or discussing use of CAM and could reply for two different doctors. Few doctors were identified as being openly against the CAM, and the majority reported being in favor of the CAM proposed.
Participants were able to identify the specific doctor or specialist whose response they were reporting, but few completed this item. Results reported in Table 5 for the doctors' response are therefore reported for all doctors combined. 
Sources of Information About CAM
Cancer support groups (61.5%), books (50%), friends (45.3%), and CAM practitioners (42.2%) were the most common sources for information about CAM (Table 6 ). Participants were asked how confident they were that the information from that source was accurate. The 4-point response scale ranged from not at all confident to very confident, with a higher score meaning higher confidence ( Table 6 ). The greatest confidence was reported if the source of information was a cancer support group (mean = 3.70), a CAM practitioner (mean = 3.68), or a medical person other than a doctor (mean = 3.67). The least confidence was reported for television and magazines as a source of CAM information. Participants felt they had about the same knowledge of CAM, or were more well informed about CAM, than most people, with the mean score being 3.46 (SD = 1.1).
Importance of CAM
Participants were asked about the importance of CAM to themselves in three areas. Response to these questions was on a 5-point scale. When asked how important CAM is for relieving symptoms from cancer and its treatment, the mean score was 3.76 (SD = 1.3), indicating that CAM was somewhat to very important for this purpose. How important CAM is in determining whether they remain free from (or defeat) cancer in the future resulted in a mean score of 4.00 (SD = 1.1), indicating that participants perceived CAM as very important in helping them defeat cancer. How important is CAM for your quality of life/well-being resulted in a mean score of 4.25 (SD = 0.8), indicating CAM was perceived as very to Note. CAM = complementary and alternative medicine; GP = general practitioner. a. Percent of those who answered these questions. b. Numbers are less than for GP due to missing data.
extremely important for quality of life. Overall, participants felt they received a lot of the benefit they were hoping for by using CAM (mean = 4.57, SD = 0.8).
DISCUSSION
The aim of this study was to develop and trial a questionnaire to systematically investigate the whole process of CAM use in cancer survivors. Previous studies have reported, among survivors of various cancers, CAM use rates of 53% (Miller et al., 1998) , 83.3% (Richardson et al., 2000) , and 21.9% (Begbie et al., 1996) ; for breast cancer, CAM use rates of 28.1% (Burnstein, Gelber, Guadagnoli, & Weeks, 1999) ; for prostate cancer, CAM use rates of 37% (Hall, Bissonette, & Theodorescu, 2003) ; and for a study of breast and prostate cancer survivors, CAM use rates of 30% (Salmenpera, 2002) . In this group of cancer survivors, CAM use was common. Results from this study fell between previous rates in studies on various cancers, with 63% of cancer survivors reporting use of at least one CAM supplement or therapy. Of those reporting use of CAM in this study, 70% reported three or more CAMs used at some time since diagnosis. The CAM users were better educated than the nonusers, which is consistent with other studies (Burnstein et al., 1999; Downer et al., 1994; Miller et al., 1998) .
The most commonly used CAMs were regular exercise, meditation, fresh fruit or vegetable juices, yoga or tai chi, remedial massage, prayer or mental healing, and art or dance therapy. These CAMs are less likely to cause adverse effects or interact with conventional cancer treatment (Miller et al., 1998) . Less commonly reported were CAMs such as shark or bovine cartilage (n = 6) and high-dose vitamin C, which may have a greater potential for interaction or adverse effects.
Expectations from CAM for all participants were related to assisting conventional treatment and recovery, feeling more in control, and enhancing quality of life. Few participants used CAM in an attempt to cure the cancer or because they were unhappy with conventional treatment. Participants rated the importance of CAM for quality of life and well-being higher than the importance for defeating/remaining free from cancer. This demonstrates that this group of cancer survivors had realistic expectations about benefits they may receive from using CAM. Overall, participants felt they received a lot of benefit from the CAM they were using.
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The findings in this study that 65.3% of participants had disclosed use of CAM to their doctor is higher than a previous study of breast cancer survivors, which found that overall 33% of the women had disclosed use of CAM to their doctor, whereas 54% of those being treated by an alternative practitioner disclosed use of CAM to their doctor (Adler & Fosket, 1999) . Results are comparable with another study of CAM in breast cancer survivors, where 72.3% of the women indicated they had reported use of CAM to their doctors (Ashikaga, Bosompra, O'Brien, & Nelson, 2002) . On a positive note, more than 75% of the doctors identified by participants in this study were reported as being in favor of the CAM that was discussed. This could be due to the most popular CAM being the more "mainstream" of CAM therapies and supplements, such as regular exercise, meditation, yoga/tai chi, massage, and fresh juices. Support groups were found to be the main source of information about CAM. Support groups offer a supportive environment to discuss problems, become more active in treatment decisions, and are ideal for sharing information about CAM products and therapies that have been found to be useful (Lindelmam, Strang, & Lekander, 2005) . Overall, participants were happy with the source(s) they used for information on CAM and, with an average mean confidence in source score of higher than 3 (of a maximum score of 4), were confident that the information was accurate.
Interestingly, with the ease of access to health information available on the Internet (Ziebland, 2004) , only 18.9% of participants had used the Internet as a source of CAM information. With more than half the population of Internet users in the United States having used the Internet to seek health information (Marcus, Nigg, Riebe, & Forsyth, 2000) , this rate appears low. The low rate could be due to the life-threatening nature of cancer as opposed to health in general, necessitating this group being more careful in sourcing information. Another possible reason is the fact that they may not have been seeking information on a specific CAM, which they would need to conduct a search using a search engine, but rather were open to information from others on any possible help.
A limitation of the questionnaire in its current form was a difficulty in relating the expected benefits and received benefits with the individual CAM used. Participants were asked to rank the three most important overall reasons for using up to three CAMs, and very few completed this section. It may be that it is too difficult for cancer survivors to choose the most important reasons for commencing CAM use; perhaps many expectations of benefits are equally important.
The results from the pilot trial of this CAM use in cancer questionnaire demonstrate that it proved useful to gain a greater knowledge of the whole process of CAM use among cancer patients and survivors. Further studies are needed with bigger sample sizes to confirm whether findings can be generalized to the larger population of Australian cancer patients and survivors. A greater focus on men is needed, as the majority of participants in this study were women. The addition of a measure of quality of life or well-being would also be important, to explore whether use of CAM is related to an improved quality of life.
